Presentation and progression of childhood-onset inflammatory bowel disease in northern Stockholm County

Inflammatory Bowel Diseases

Volumn 21, Issue 5, 2015, Pages 1098-1108

  Malmborg, Petter ^a   Grahnquist, Lena ^a   Ideström, Maja ^a   Lindholm, Johan ^a   Befrits, Ragnar ^a   Björk, Jan ^a   Montgomery, Scott ^b,c,d   Hildebrand, Hans ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

childhood onset inflammatory bowel disease; Crohn's disease; mucosal healing; prognosis; ulcerative colitis

Indexed keywords

ABDOMINAL SURGERY; ADVERSE OUTCOME; ARTICLE; CHILD; CHILDHOOD DISEASE; CLINICAL FEATURE; COHORT ANALYSIS; COLON RESECTION; CROHN DISEASE; DISEASE ACTIVITY; DISEASE COURSE; FEMALE; FOLLOW UP; GASTROINTESTINAL ENDOSCOPY; HUMAN; INFLAMMATORY BOWEL DISEASE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ONSET AGE; PANCOLITIS; PRIORITY JOURNAL; RISK ASSESSMENT; ULCERATIVE COLITIS; ADOLESCENT; INCIDENCE; INFANT; INFLAMMATORY BOWEL DISEASES; MEDICAL RECORD; PHENOTYPE; PRESCHOOL CHILD; PROGNOSIS; RISK FACTOR; SEVERITY OF ILLNESS INDEX; SWEDEN; TIME;

ADOLESCENT; AGE OF ONSET; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; INFANT; INFLAMMATORY BOWEL DISEASES; MALE; MEDICAL RECORDS; PHENOTYPE; PROGNOSIS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SWEDEN; TIME FACTORS;

EID: 84929070199     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/MIB.0000000000000356     Document Type: Article

References (50)

1. Braegger CP, Ballabeni P, Rogler D, et al. Epidemiology of inflammatory bowel disease: is there a shift towards onset at a younger age?. J Pediatr Gastroenterol Nutr. 2011;53:141-144.
2. Benchimol EI, Fortinsky KJ, Gozdyra P, et al. Epidemiology of pediatric inflammatory bowel disease: a systematic review of international trends. Inflamm Bowel Dis. 2011;17:423-439.
3. Hildebrand H, Finkel Y, Grahnquist L, et al. Changing pattern of paediatric inflammatory bowel disease in northern Stockholm 1990-2001. Gut. 2003;52:1432-1434.
4. Benchimol EI, Guttmann A, Griffiths AM, et al. Increasing incidence of paediatric inflammatory bowel disease in Ontario, Canada: evidence from health administrative data. Gut. 2009;58:1490-1497.
5. Lehtinen P, Ashorn M, Iltanen S, et al. Incidence trends of pediatric inflammatory bowel disease in Finland, 1987-2003, a nationwide study. Inflamm Bowel Dis. 2011;17:1778-1783.
6. Malmborg P, Grahnquist L, Lindholm J, et al. Increasing incidence of paediatric inflammatory bowel disease in northern Stockholm County 2002-2007. J Pediatr Gastroenterol Nutr. 2013;57:29-34.
7. Griffiths AM. Specificities of inflammatory bowel disease in childhood. Best Pract Res Clin Gastroenterol. 2004;18:509-523.
8. Satsangi J, Silverberg MS, Vermeire S, et al. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut. 2006;55:749-753.
9. Levine A, Griffiths A, Markowitz J, et al. Pediatric modification of the Montreal classification for inflammatory bowel disease: the Paris classification. Inflamm Bowel Dis. 2011;17:1314-1321.
10. van Limbergen J, Russell RK, Drummond HE, et al. Definition of phenotypic characteristics of childhood-onset inflammatory bowel disease. Gastroenterology. 2008;135:1114-1122.
11. Jakobsen C, Bartek J, Wewer V, et al. Differences in phenotype and disease course in adult and paediatric inflammatory bowel disease-A population-based study. Aliment Pharmacol Ther. 2011;34:1217-1224.
12. Lovasz BD, Lakatos L, Horvath A, et al. Evolution of disease phenotype in adult and pediatric onset Crohn's disease in a population-based cohort. World J Gastroenterol. 2013;19:2217-2226.
13. Israeli E, Ryan JD, Shafer LA, et al. Younger age at diagnosis is associated with pan-enteric, but not more aggressive, Crohn's disease. Clin Gastroenterol Hepatol. 2014;12:72-79.
14. Vernier-Massouille G, Balde M, Salleron J, et al. Natural history of pediatric Crohn's disease: a population-based cohort study. Gastroenterology. 2008;135:1106-1113.
15. Gower-Rousseau C, Dauchet L, Vernier-Massouille G, et al. The natural history of pediatric ulcerative colitis: a population-based cohort study. Am J Gastroenterol. 2009;104:2080-2088.
16. Markowitz J, Hyams J, Mack D, et al. Corticosteroid therapy in the age of infliximab: acute and 1-year outcomes in newly diagnosed children with Crohn's disease. Clin Gastroenterol Hepatol. 2006;4: 1124-1129.
17. Hyams J, Markowitz J, Lerer T, et al. The natural history of corticosteroid therapy for ulcerative colitis in children. Clin Gastroenterol Hepatol. 2006;4:1118-1123.
18. Pigneur B, Seksik P, Viola S, et al. Natural history of Crohn's disease: comparison between childhood-And adult-onset disease. Inflamm Bowel Dis. 2010;16:953-961.
19. Hope B, Shahdadpuri R, Dunne C, et al. Rapid rise in incidence of Irish paediatric inflammatory bowel disease. Arch Dis Child. 2012; 97:590-594.
20. Vermeire S, van Assche G, Rutgeerts P. Altering the natural history of Crohn's disease-evidence for and against current therapies. Aliment Pharmacol Ther. 2007;25:3-12.
21. D'Haens G, Ferrante M, Vermeire S, et al. Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease. Inflamm Bowel Dis. 2012;18:2218-2224.
22. Schreiber S, Colombel JF, Bloomfield R, et al. Increased response and remission rates in short-duration Crohn's disease with subcutaneous certolizumab pegol: an analysis of PRECiSE 2 randomized maintenance trial data. Am J Gastroenterol. 2010;105:1574-1582.
23. Colombel JF, Sandborn WJ, Reinisch W, et al. Infliximab, azathioprine, or combination therapy for Crohn's disease. N Engl J Med. 2010;362:1383-1395.
24. Louis E. Epidemiology of the transition from early to late Crohn's disease. Dig Dis. 2012;30:376-379.
25. Mackey AC, Green L, Leptak C, et al. Hepatosplenic T cell lymphoma associated with infliximab use in young patients treated for inflammatory bowel disease: update. J Pediatr Gastroenterol Nutr. 2009;48:386-388.
26. Hildebrand H, Brydolf M, Holmquist L, et al. Incidence and prevalence of inflammatory bowel disease in children in South-Western Sweden. Acta Paediatr. 1994;83:640-645.
27. Beaugerie L, Seksik P, Nion-Larmurier I, et al. Predictors of Crohn's disease. Gastroenterology. 2006;130:650-656.
28. Wright JG, Feinstein AR. A comparative contrast of clinimetric and psychometric methods for constructing indexes and rating scales. J Clin Epidemiol. 1992;45:1201-1218.
29. Cepeda MS, Boston R, Farrar JT, et al. Comparison of logistic regression versus propensity score when the number of events is low and there are multiple confounders. Am J Epidemiol. 2003;158:280-287.
30. Lapidus A. Crohn's disease in Stockholm County during 1990-2001: an epidemiological update. World J Gastroenterol. 2006;12:75-81.
31. Perminow G, Brackmann S, Lyckander LG, et al. A characterization in childhood inflammatory bowel disease, a new population-based inception cohort from South-Eastern Norway, 2005-2007, showing increased incidence in Crohn's disease. Scand J Gastroenterol. 2009;44:446-456.
32. Jakobsen C, Paerregaard A, Munkholm P, et al. Pediatric inflammatory bowel disease: increasing incidence, decreasing surgery rate, and compromised nutritional status: a prospective population-based cohort study 2007-2009. Inflamm Bowel Dis. 2011;17:2541-2550.
33. Kugathasan S, Judd RH, Hoffmann RG, et al. Epidemiologic and clinical characteristics of children with newly diagnosed inflammatory bowel disease in Wisconsin: a statewide population-based study. J Pediatr. 2003; 143:525-531.
34. Solberg IC, Lygren I, Jahnsen J, et al. Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study). Scand J Gastroenterol. 2009;44:431-440.
35. Solberg IC, Vatn MH, Hoie O, et al. Clinical course in Crohn's disease: results of a Norwegian population-based ten-year follow-up study. Clin Gastroenterol Hepatol. 2007;5:1430-1438.
36. Cosnes J, Bourrier A, Nion-Larmurier I, et al. Factors affecting outcomes in Crohn's disease over 15 years. Gut. 2012;61:1140-1145.
37. Munkholm P, Langholz E, Davidsen M, et al. Disease activity courses in a regional cohort of Crohn's disease patients. Scand J Gastroenterol. 1995;30:699-706.
38. Sjoberg D, Holmstrom T, Larsson M, et al. Incidence and natural history of ulcerative colitis in the Uppsala region of Sweden 2005-2009-results from the IBD Cohort of the Uppsala Region (ICURE). J Crohns Colitis. 2013;7:e351-e357.
39. Gasche C, Scholmerich J, Brynskov J, et al. A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis. 2000;6:8-15.
40. Henriksen M, Jahnsen J, Lygren I, et al. Ulcerative colitis and clinical course: results of a 5-year population-based follow-up study (the IBSEN study). Inflamm Bowel Dis. 2006;12:543-550.
41. Henriksen M, Jahnsen J, Lygren I, et al. Clinical course in Crohn's disease: results of a five-year population-based follow-up study (the IBSEN study). Scand J Gastroenterol. 2007;42:602-610.
42. Rungoe C, Langholz E, Andersson M, et al. Changes in medical treatment and surgery rates in inflammatory bowel disease: a nationwide cohort study 1979-2011. Gut. 2013;20:2013-305607.
43. Nguyen GC, Nugent Z, Shaw S, et al. Outcomes of patients with Crohn's disease improved from 1988 to 2008 and were associated with increased specialist care. Gastroenterology. 2011;141:90-97.
44. Lakatos PL, Golovics PA, David G, et al. Has there been a change in the natural history of Crohn's disease?. Surgical rates and medical management in a population-based inception cohort from Western Hungary between 1977-2009. Am J Gastroenterol. 2012;107:579-588.
45. Ramadas AV, Gunesh S, Thomas GA, et al. Natural history of Crohn's disease in a population-based cohort from Cardiff (1986-2003): a study of changes in medical treatment and surgical resection rates. Gut. 2010;59:1200-1206.
46. Savoye G, Salleron J, Gower-Rousseau C, et al. Clinical predictors at diagnosis of disabling pediatric Crohn's disease. Inflamm Bowel Dis. 2012;18:2072-2078.
47. Froslie KF, Jahnsen J, Moum BA, et al. Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort. Gastroenterology. 2007;133:412-422.
48. Inflammatory bowel disease in children and adolescents: recommendations for diagnosis-The Porto criteria. J Pediatr Gastroenterol Nutr. 2005;41:1-7.
49. Levine A, Koletzko S, Turner D, et al. The ESPGHAN revised porto criteria for the diagnosis of inflammatory bowel disease in children and adolescents. J Pediatr Gastroenterol Nutr. 2014;58:795-806.
50. Hertervig E, Befrits R, Ekbom A, et al. Colitis cancer-myth or reality?. Lakartidningen. 2009;106:3000-3002.